DAVID BALTIMORE
CIK 1185858 · last filed 2025-06-27
DAVID BALTIMORE is a corporate insider who has filed 51 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for RGLS, was dated Jun 27, 2025. Across all open-market trades the lifetime net is −$4.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $11.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$11.47M
3
51
-$4.04M
Holdings By Company
Recent Filings
51 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-27 | Regulus Therapeutics Inc. (RGLS) Delisted | Mixed | −147,169 | $0 | EDGAR |
| 2025-04-30 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | +125,000 | $0 | EDGAR |
| 2025-01-31 | Regulus Therapeutics Inc. (RGLS) Delisted | Buy (P) | +19,610 | $20.8K | EDGAR |
| 2024-05-21 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-05-17 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-08-14 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-13 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-10 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-15 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-01-27 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | — | $0 | EDGAR |